HDAC4
Histone deacetylase 4
Also known as: BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDAC4_HUMAN, HDACA, KIAA0288
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P56524
- Gene
- HDAC4
- Ensembl
- ENSG00000068024
- Chromosome
- 2
- Canonical length
- 1084 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear speckles,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to class II of the histone deacetylase/acuc/apha family. It possesses histone deacetylase activity and represses transcription when tethered to a promoter. This protein does not bind DNA directly, but through transcription factors MEF2C and MEF2D. It seems to interact in a multiprotein complex with RbAp48 and HDAC3. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1084 residues, UniProt reviewed canonical sequence.
>P56524|HDAC4
1 MSSQSHPDGL SGRDQPVELL NPARVNHMPS TVDVATALPL QVAPSAVPMD LRLDHQFSLP
61 VAEPALREQQ LQQELLALKQ KQQIQRQILI AEFQRQHEQL SRQHEAQLHE HIKQQQEMLA
121 MKHQQELLEH QRKLERHRQE QELEKQHREQ KLQQLKNKEK GKESAVASTE VKMKLQEFVL
181 NKKKALAHRN LNHCISSDPR YWYGKTQHSS LDQSSPPQSG VSTSYNHPVL GMYDAKDDFP
241 LRKTASEPNL KLRSRLKQKV AERRSSPLLR RKDGPVVTAL KKRPLDVTDS ACSSAPGSGP
301 SSPNNSSGSV SAENGIAPAV PSIPAETSLA HRLVAREGSA APLPLYTSPS LPNITLGLPA
361 TGPSAGTAGQ QDAERLTLPA LQQRLSLFPG THLTPYLSTS PLERDGGAAH SPLLQHMVLL
421 EQPPAQAPLV TGLGALPLHA QSLVGADRVS PSIHKLRQHR PLGRTQSAPL PQNAQALQHL
481 VIQQQHQQFL EKHKQQFQQQ QLQMNKIIPK PSEPARQPES HPEETEEELR EHQALLDEPY
541 LDRLPGQKEA HAQAGVQVKQ EPIESDEEEA EPPREVEPGQ RQPSEQELLF RQQALLLEQQ
601 RIHQLRNYQA SMEAAGIPVS FGGHRPLSRA QSSPASATFP VSVQEPPTKP RFTTGLVYDT
661 LMLKHQCTCG SSSSHPEHAG RIQSIWSRLQ ETGLRGKCEC IRGRKATLEE LQTVHSEAHT
721 LLYGTNPLNR QKLDSKKLLG SLASVFVRLP CGGVGVDSDT IWNEVHSAGA ARLAVGCVVE
781 LVFKVATGEL KNGFAVVRPP GHHAEESTPM GFCYFNSVAV AAKLLQQRLS VSKILIVDWD
841 VHHGNGTQQA FYSDPSVLYM SLHRYDDGNF FPGSGAPDEV GTGPGVGFNV NMAFTGGLDP
901 PMGDAEYLAA FRTVVMPIAS EFAPDVVLVS SGFDAVEGHP TPLGGYNLSA RCFGYLTKQL
961 MGLAGGRIVL ALEGGHDLTA ICDASEACVS ALLGNELDPL PEKVLQQRPN ANAVRSMEKV
1021 MEIHSKYWRC LQRTTSTAGR SLIEAQTCEN EEAETVTAMA SLSVGVKPAE KRPDEEPMEE
1081 EPPLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HDAC4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 33 nTPM
- tongue: 25 nTPM
- bone marrow: 14 nTPM
- colon: 12 nTPM
- cerebral cortex: 8.1 nTPM
- testis: 8 nTPM
Single-cell type
- myonuclei: 1,091 nCPM
- neutrophils: 673 nCPM
- renal connecting tubule cells: 372 nCPM
- neutrophil progenitors: 363 nCPM
- somatotrophs: 342 nCPM
- pituicytes/fscs: 315 nCPM
Immune cell
- neutrophil: 47 nTPM
- basophil: 32 nTPM
- classical monocyte: 9.8 nTPM
- intermediate monocyte: 3.3 nTPM
- NK-cell: 2.9 nTPM
- eosinophil: 2 nTPM
Brain region
- cerebral cortex: 56 nTPM
- pons: 51 nTPM
- white matter: 48 nTPM
- basal ganglia: 47 nTPM
- medulla oblongata: 45 nTPM
- hypothalamus: 43 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HDAC4.
Disease | AllUniProt
Conditions HDAC4 is implicated in, by any mechanism.
- Neurodevelopmental disorder with central hypotonia and dysmorphic facies (NEDCHF) MIM:619797
Disease | GeneticClinVar
12 pathogenic / likely-pathogenic of 737 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodevelopmental disorder with central hypotonia and dysmorphic facies
- Chromosome 2q37 deletion syndrome
- Profound intellectual disability
- Inborn genetic diseases
- Brachydactyly syndrome type E
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.05
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.93
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell activation
- B cell differentiation
- cardiac muscle hypertrophy in response to stress
- chromatin remodeling
- epigenetic regulation of gene expression
- inflammatory response
- negative regulation of gene expression, epigenetic
- negative regulation of glycolytic process
- negative regulation of myotube differentiation
- negative regulation of protein refolding
- negative regulation of transcription by competitive promoter binding
- negative regulation of transcription by RNA polymerase II
- nervous system development
- positive regulation of cell population proliferation
- positive regulation of DNA-templated transcription
- positive regulation of protein sumoylation
- positive regulation of transcription by RNA polymerase II
- protein sumoylation
- response to denervation involved in regulation of muscle adaptation
- response to interleukin-1
- type I interferon-mediated signaling pathway
Molecular functions
- DNA-binding transcription activator activity
- DNA-binding transcription factor binding
- histone deacetylase activity
- histone deacetylase activity, hydrolytic mechanism
- histone deacetylase binding
- identical protein binding
- molecular adaptor activity
- potassium ion binding
- protein lysine deacetylase activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- SUMO transferase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HDAC4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HDAC4 as an antibody target. Whether an autoantibody or antibody against HDAC4 could matter depends on whether native HDAC4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HDAC4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HDAC4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...